SCHEMBL2883216

SCHEMBL2883216

c1ccc(-c2ccccc2-c2nc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6-c6ccccc6)nc(-c6ccccc6-c6ccccc6)n5)cc4)cc3)nc(-c3ccccc3-c3ccccc3)n2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
GPR55 Q9Y2T6 1/20 0.52
ADORA2A P29274 3/20 0.52
ADORA1 P30542 3/20 0.52
ADORA3 P0DMS8 2/20 0.52
ADORA2B P29275 2/20 0.52
TSHR P16473 2/20 0.52
ALOX15 P16050 1/20 0.52
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
MAPT P10636 4/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 2/20 0.48
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
MAPK1 P28482 1/20 0.44
NTSR1 P30989 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17720965 1.00 L3MBTL1 (0.52) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL27455503 1.00 L3MBTL1 (0.52) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL17720962 0.98 ADORA2A (0.50) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL21037520 0.98 ADORA2A (0.50) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL24689432 0.95 L3MBTL1 (0.52) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL31290117 0.95 L3MBTL1 (0.52) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL21922946 0.95 L3MBTL1 (0.56) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL19762125 0.95 L3MBTL1 (0.56) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL19497492 0.95 L3MBTL1 (0.56) L3MBTL1GPR55ADORA2AADORA1ADORA3
SCHEMBL18270333 0.94 MEN1 (0.48) L3MBTL1GPR55ADORA2AADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6229012-B1 ORGANIC ELECTROLUMINESCENT DEVICES XEROX CORPORATION 2001-05-08 US claimed
US-9085729-B2 Blue emitters for use in organic electroluminescence devices LG DISPLAY CO., LTD. (KR) 2015-07-21 US disclosed
EP-1669428-B1 Organic electroluminescent devices LG DISPLAY CO LTD (KR) 2013-07-24 EP disclosed
US-8487527-B2 Organic light emitting devices LG DISPLAY CO., LTD. (KR) 2013-07-16 US disclosed
US-7777407-B2 Organic light emitting devices comprising a doped triazine electron transport layer LG DISPLAY CO., LTD. (KR) 2010-08-17 US disclosed
US-7402346-B2 Organic electroluminescent devices LG. PHILIPS LCD CO., LTD. (KR) 2008-07-22 US disclosed
US-20060251920-A1 Organic light emitting devices comprising a doped triazine electron transport layer XEROX CORPORATION 2006-11-09 US disclosed
US-20060251919-A1 Organic light emitting devices XEROX CORPORATION 2006-11-09 US disclosed
EP-1669428-A1 Organic electroluminescent devices L.G. Philips LCD Co., Ltd. (KR) 2006-06-14 EP disclosed
US-20060121311-A1 Organic electroluminescent devices XEROX CORPORATION. 2006-06-08 US disclosed
US-20050175857-A1 Element including fluorescent 1,1'-binaphthyl derivative; uniform luminescence, saturated color; thermal stability; performance; vacuum deposition thin films; enhanced charge transporting, reduced driving voltage XEROX CORPORATION (US) 2005-08-11 US disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 US disclosed
US-6562485-B2 Electroluminescent (EL) devices XEROX CORPORATION 2003-05-13 US disclosed
US-20030044646-A1 Electroluminescent (EL) devices XEROX CORPORATION 2003-03-06 US disclosed
US-6479172-B2 PERFORMANCE, THERMOSTABILITY XEROX CORPORATION 2002-11-12 US disclosed
US-20020132134-A1 Electroluminescent (EL) devices XEROX CORPORATION 2002-09-19 US disclosed
US-6229012-B1 ORGANIC ELECTROLUMINESCENT DEVICES XEROX CORPORATION 2001-05-08 US disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 US disclosed
US-6057048-A Electroluminescent (EL) devices XEROX CORPORATION (US) 2000-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060121311-A1 Organic electroluminescent devices KCNH3, GLUL, ARGLU1 L3MBTL1 750/4885GPR55 3448/4885ADORA2A 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.